Johnson & Johnson (NYSE:JNJ) on Monday secured U.S. 510(k) regulatory clearance for MONARCH QUEST 3, the newest software iteration for its robotically-assisted bronchoscopy platform.
The update focuses on improving clinical confidence during complex airway procedures and marks the fourth launch for the MONARCH system in the past 18 months, demonstrating a clear push for continuous medical innovation.
Advances Robotic Bronchoscopy
The MONARCH system operates as the first flexible, robotically-assisted platform designed to help physicians visualize and access patient airways for diagnostic and therapeutic procedures.
With the QUEST 3 update, the healthcare company addresses anatomical changes and CT-to-body divergence that frequently happen during clinical interventions, giving physicians precise control and stable reach.
